Business Context and Reporting Period
This Form 8-K filing by Lantronix, Inc. reports corporate governance events occurring on May 6, 2010. The report details the appointment of two new independent directors to the Board of Directors.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel changes and associated equity compensation.
Material Changes
The primary material change is the expansion of the Board of Directors with the addition of two independent members:
- Marcelo G. Lima: Appointed as an independent director. He brings over 25 years of experience in the medical industry, including roles at ImThera Medical, Visage Imaging, and Kodak.
- John Rehfeld: Appointed as an independent director. He has extensive executive experience, including former CEO roles at Spruce Technologies, ProShot Golf, Proxima Corporation, and ETAK, Inc.
Compensatory Arrangements and Equity Grants
Pursuant to the Company's 2000 Stock Plan, the following grants were made on May 6, 2010:
- John Rehfeld: Granted 12,500 restricted shares of common stock.
- Marcelo G. Lima: Granted a non-statutory stock option to purchase 18,466 shares of common stock at an exercise price of $4.00 per share (fair market value on the date of grant).
Investor Verification Checklist
- Verify the independence status of Mr. Lima and Mr. Rehfeld under Nasdaq corporate governance standards.
- Review the attached press release (Exhibit 99.1) for additional context on the strategic rationale for these appointments.
- Confirm the vesting schedules and terms for the restricted shares and stock options granted under the 2000 Stock Plan.
- Note that this filing contains no financial results; refer to the most recent 10-Q or 10-K for financial metrics.